World Health Organization (WHO) delivers critical support to Bugna Woreda and surroundings amid humanitarian needs
Recognizing the urgent need for intervention, WHO mobilized resources and personnel to support Bugna Woreda and provided PED SAM kits, IEHK kits and Trauma kits support from the Central Emergency Response Fund (CERF), the European Union (ECHO) and the United States Agency for International Development (USAID). The efforts focused on improving access to essential health and nutrition services, providing critical medical supplies, and supporting vaccination campaigns. WHO worked closely with local health authorities to strengthen the capacity of health centers and health posts, ensuring that they can better serve the community despite the challenging conditions.
WHO donated medical supplies
Items
Sum of Total
(IEHK 2017, BASIC) MODULE, MALARIA
36
(IEHK 2017, BASIC) MODULE, MEDICINES
36
(IEHK 2017, BASIC) MODULE, RENEWABLE AND EQUIPMENT
12
(IEHK 2017, SUPPLEMENTARY) MODULE, MALARIA
5
(IEHK 2017, SUPPLEMENTARY) MODULE, RENEWABLE
7
(IEHK 2021, SUPPLEMENTARY) MODULE, PEP, treatments for 50 adults + 10 children
5
(Kit PED-SAM 2020) MODULE 2, MEDICINES PED ORAL
12
(Kit PED-SAM 2020) MODULE 3, MEDICINES PED INJECTABLES
12
(Kit PED-SAM 2020) MODULE 6, RENEWABLES
6
(TESK 2019 mod 1A) SET 1A5, DRUGS, DANGEROUS GOODS
4
(TESK 2019 mod 1A) SET 1A6, DRUGS, INFUSIONS
2
(TESK 2019 mod 1A) SET 1A7, DRUGS, DISINFECTANTS
6
(TESK 2019 mod 1B) SET 1B3, RENEWABLES, INJECTION MATERIAL
6
Despite operational hardships, healthcare workers remained at their posts, showing immense resilience and dedication to their community.
WHO's support was crucial in mitigating the impacts of the access challenge. It provided much-needed medical, allowing health facilities to procure essential items and pay their workers. WHO also advocated for sustained humanitarian access to Bugna Woreda, ensuring that the flow of supplies continued uninterrupted.
Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
12 hours ago
- Zawya
Ethiopia's Integrated Measles Campaign Reaches 18.5 Million Under-Five Children
Ethiopia has successfully concluded its 2025 nationwide integrated measles campaign, reaching 18,570,244 children—99% of the targeted population. The ten-day campaign began on 14 May 2025 across 12 regions, with Somali Region and Addis Ababa City Administration launching on 21 May and 26 May, respectively. The national launch event, organized by WHO, was held in Bishoftu, Oromia Region, under the leadership of the Ministry of Health and supported by partners, community members, and political leaders. Dr. Owen L. Kaluwa, WHO Representative to Ethiopia, commended the Ministry of Health for its leadership, stating: 'I would like to congratulate and commend the Ministry of Health for your leadership and effort undertaken to realize the successful implementation of the 2025 National Integrated Measles Supplementary Immunization (SIA) Campaign, and for marking a significant milestone in delivering life-saving services to vulnerable and hard-to-reach populations nationwide.' Dr. Kaluwa also reaffirmed WHO's commitment to supporting Ethiopia in strengthening routine immunization and primary health care systems to reduce child mortality. WHO provided technical and financial support throughout the campaign, including proposal development, microplanning, training, supervision, and support for the national launch event. The campaign targeted children aged 9 to 59 months, aiming to protect them against measles—a highly contagious and potentially fatal disease. It was designed to close immunity gaps and prevent outbreaks, in line with global health recommendations and in response to ongoing measles cases in parts of the country. In addition to measles vaccination, the campaign integrated several health interventions, including: Routine Immunization: 191,346 zero-dose and 211,546 under-vaccinated children received vaccines. Nutritional Screening: Over 18.9 million children under five were screened; 874,722 were identified as moderately acutely malnourished (MAM), and 122,207 as severely acutely malnourished (SAM). Vitamin A Supplementation: More than 15 million children received vitamin A. Deworming: 11,095,948 children aged 24 to 59 months received albendazole. COVID-19 Vaccination: 206,431 Pfizer doses were administered to high-priority groups. Obstetric Fistula Identification: 1,325 suspected cases were identified and referred to health facilities. Sick Child Referral: Over 49,312 sick children were identified and linked to appropriate health services. The campaign's success was made possible through the full engagement of government ministries, partners, communities, and the media, which played a vital role in raising awareness and increasing demand for the life-saving vaccine. This achievement highlights the power of collaboration and dedicated partnerships in ensuring every child has access to essential health services. WHO remains steadfast in its commitment to supporting Ethiopia in strengthening routine immunization, enhancing primary health care systems, and advancing efforts to reduce child mortality—ensuring that no child is left behind. Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Zawya
12 hours ago
- Zawya
Ethiopia Completes Second Round of novel Oral Polio Vaccine type 2 (nOPV2) Campaign, Reaching Over 16.8 Million Children with Integrated Health Services
Ethiopia has successfully concluded the second round of its nationwide novel oral polio vaccine type 2 (nOPV2) campaign, reaching more than 16.8 million children across ten regions. Led by the Ministry of Health and the Ethiopian Public Health Institute and supported by the World Health Organization (WHO), UNICEF, Rotary International, and other immunization partners, the campaign was conducted from 30 May to 2 June 2025. With an administrative coverage of 105%, the campaign integrated essential maternal and child health services to maximize its reach and impact. While the primary target group was children under five, the age range was extended to include children up to ten years in Kellem and West Guji zones of Oromia Region, following localized risk assessments. 'Ethiopia's leadership and coordination have been exemplary,' said Dr Owen L. Kaluwa, WHO Representative in Ethiopia. 'In the first round, over 15.3 million children were vaccinated with nOPV2, achieving 103% coverage. These efforts are vital as the country continues to respond to outbreaks, with 69 cases reported across multiple regions between 2024 and March 2025.' Throughout the campaign, WHO played a pivotal role in ensuring its success. In close collaboration with the Ethiopian Public Health Institute and UNICEF, WHO supported pre-campaign preparations, including resource mobilization, training of health workers, and real-time monitoring using tools like the Open Data Kit (ODK). WHO also deployed independent monitors and quality assurance surveyors in nearly half of the selected regions, enabling immediate corrective actions and contributing to higher coverage rates. Additionally, WHO Field Officers and STOP consultants supported preparedness assessments, microplanning, cold chain inventory, and training of team supervisors. The integrated campaign strategy is central to reducing mortality and morbidity from vaccine-preventable diseases. During the first round, a total of 104,000 zero-dose (62,000) and under-vaccinated children (42,000) were identified and vaccinated—highlighting the campaign's success in reaching previously missed populations. Key Achievements from the Second Round are: 48,363 zero-dose children vaccinated, bringing the cumulative total to over 110,000 across both rounds. 654 children immunized at official border entry points with Sudan, Kenya, Somalia, and South Sudan. 31,253 supervisory visits conducted, resulting in 365 acute flaccid paralysis (AFP) alerts, with 81 confirmed cases and samples collected for laboratory analysis. Independent monitoring and Lot Quality Assurance Sampling (LQAS) surveys confirmed high campaign quality, with 98% of 52,120 children verified as vaccinated and 90% of lots passing the quality threshold. In addition to nOPV2 vaccination, the campaign facilitated catch-up immunizations for zero-dose and under-vaccinated children and supported the identification and referral of women with obstetric fistula for treatment—demonstrating a holistic approach to public health. WHO remains committed to supporting Ethiopia's regions, zones, and woredas in achieving high immunization coverage and maintaining robust disease surveillance systems to protect every child. Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Zawya
a day ago
- Zawya
The World Health Organization (WHO) Director-General and Regional Director for Africa begin official visit to Ghana ahead of Africa Health Sovereignty Summit
The Director-General of the World Health Organization (WHO), Dr Tedros Adhanom Ghebreyesus, and the WHO Regional Director for Africa, Dr Mohammed Yakubu Janabi, have commenced an official visit to Ghana from 4–6 August 2025. Their visit comes ahead of the Africa Health Sovereignty Summit: The Accra Compact, scheduled for 5 August in Accra, and signals a renewed commitment to advancing regional cooperation on sustainable financing for health and systems resilience. The Summit takes place at a time of mounting global health challenges and constrained financing, with countries across Africa striving to build stronger, more resilient health systems. Ghana's recent progress in universal health coverage, local vaccine manufacturing, and emergency preparedness demonstrates the country's growing leadership in shaping sustainable and equitable health outcomes. During their stay, Dr Tedros and Dr Janabi will hold high-level meetings with national authorities including H.E. John Dramani Mahama, President of the Republic of Ghana and key stakeholders to reaffirm WHO's support for Ghana's health priorities. The summit will convene African heads of state, health ministers, and global partners to align national, regional, and global agendas around the principles of self-reliance, innovation, and coordinated action. The delegation includes senior officials from WHO headquarters in Geneva, the WHO Regional Office for Africa, and the WHO Ghana Country Office. The visit is expected to reaffirm WHO's technical partnership with Ghana while spotlighting the country's leadership in advancing inclusive and sustainable health development across the continent. Distributed by APO Group on behalf of World Health Organization (WHO), Ghana.
